Salkantay Ventures

Salkantay Ventures is a Lima-based fund investing in high-growth companies from Spanish-speaking Latin America that leverage technology for social progress. Check sizes of $250k to $1M place the firm in the seed range, suitable for participating in or anchoring small priced rounds. Healthcare exposure is concentrated in digital health and health IT, with explicit AI-thematic interest. The firm’s positioning blends financial venture with social impact emphasis, which informs both the deal selection and the LP base.

The firm’s natural fit is with Andean and broader Spanish-speaking LatAm founders building tech-enabled platforms with measurable social outcomes alongside commercial returns. For healthcare founders, this means digital health platforms expanding access to underserved populations, AI tools that improve clinical decision-making in resource-constrained settings, or health-IT software that improves the efficiency of public-private health systems. Founders building DTC consumer health for affluent urban segments without a clear social-progress angle will find weaker thesis fit. Pure US-market founders are not the natural target.

Geographically, the firm’s advantage is its Andean coverage (Peru, Colombia, Ecuador, Bolivia, Chile) and connectivity to broader Spanish-speaking LatAm. Peru’s regulatory and payer dynamics differ meaningfully from Brazil and Mexico, and Salkantay can be a valuable navigator for founders unfamiliar with the local environment. For founders looking to use Lima as an operational base or as a regional springboard, the firm is a credible partner.

The right entry path is a warm intro from an Andean GP, an existing portfolio founder, or a regional accelerator like UTEC Ventures. The firm reads partner-led decks and responds to clear regional theses with measurable impact metrics. The pitch should lead with the social-progress thesis (specific impact metrics, target populations, measurable outcomes), unit economics, and a credible regional expansion plan. AI narrative should connect to specific clinical or operational outcomes rather than to model performance benchmarks.

Caveats. Impact-tilted funds may have non-financial reporting expectations and LP-driven constraints; review the LP base and reporting requirements before signing. Andean fund structures interact with cross-border venture dynamics in idiosyncratic ways; involve regional corporate counsel early. The healthcare-specific portfolio depth is not as visible publicly as that of larger LatAm health funds; reference calls with two existing portfolio founders are advisable. For Andean founders building tech-enabled healthcare platforms with credible social outcomes, Salkantay is a thoughtful early partner; for founders chasing pure financial returns or operating without regional ties, the fit is weaker.